牧原股份(002714.SZ):加快實施回購公司股份
格隆匯4月8日丨牧原股份(002714.SZ)公佈,截至2025年3月31日,公司通過股份回購專用證券賬户以集中競價方式累計回購公司股份3,124.70萬股,佔公司目前總股本的0.57%,最高成交價為42.96元/股,最低成交價為36.16元/股,成交總額為124,992.74萬元(不含交易費用)。
中國經濟基礎穩、優勢多、韌性強、潛能大,長期向好的支撐條件和基本趨勢沒有變。基於對公司未來發展及公司價值的信心,公司將加快實施回購公司股份,以維護廣大投資者的利益,增強投資者對公司的投資信心,穩定及提升公司價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.